| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 [K. K., N. O., G. M., A. B. P.]; Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129 [E. L.]; and St. Elizabeth's Medical Center, Boston, Massachusetts 02135 [H. J. F.]
2 To whom requests for reprints should be addressed, at New York State Department of Health, Wadsworth Center for Laboratories and Research, Empire State Plaza, Room C-362, P. O. Box 509, Albany, NY 12201-0509.
A fundamental cause of cancer is changed properties of genetic material, which may deregulate normal development of the tissue or provide selective growth advantage to the tumor cell. This deregulation of cell proliferation results from altered production of a handful of proteins that play key roles in progression through the eukaryotic cell cycle. Some of these proteins include tumor suppressor genes or oncogenes.
However, no one general change or alteration of a critical gene has yet been found in all cancers. Using surgical material obtained from patients with various malignancies, we show that breast cancers and other solid tumors, as well as malignant lymphocytes from patients with lymphatic leukemia, show severe quantitative and qualitative alterations in cyclin E protein production independent of the S-phase fraction of the samples. Hence, these alterations represent a true difference between normal versus tumor tissue. In addition, in breast cancer, the alterations in cyclin E expression become progressively worse with increasing stage and grade of the tumor, suggesting its potential use as a new prognostic marker.
1 This work was supported in part by a National Research Service Award CA08949-02 (to K. K.) from the NIH, a Breast Cancer Research Initiative Grant SC-DPH-3407-311-7051 from the Massachusetts Department of Health (to K. K.), a fellowship from the Science and Engineering Research Council (to E. L.) and a Public Health Service Grant GM 24571 (to A. B. R).
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 12/ 8/93. Accepted 12/14/93.
This article has been cited by other articles:
|
|
 |
|
  L. L. Gorges, N. H. Lents, and J. J. Baldassare The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1151 - C1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A N A Milne, R Carvalho, M Jansen, E K Kranenbarg, C J H van de Velde, F M Morsink, A R Musler, M A J Weterman, and G J A Offerhaus Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival J. Clin. Pathol., March 1, 2008; 61(3): 311 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Berglund, M Stighall, K Jirstrom, L Ryden, M Ferno, B Nordenskjold, and G Landberg Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern J. Clin. Pathol., February 1, 2008; 61(2): 184 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Akli, C. S. Van Pelt, T. Bui, A. S. Multani, S. Chang, D. Johnson, S. Tucker, and K. Keyomarsi Overexpression of the Low Molecular Weight Cyclin E in Transgenic Mice Induces Metastatic Mammary Carcinomas through the Disruption of the ARF-p53 Pathway Cancer Res., August 1, 2007; 67(15): 7212 - 7222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Porter, W. E. Barlow, I-T. Yeh, M. G. Lin, X. P. Yuan, E. Donato, G. W. Sledge, C. L. Shapiro, J. N. Ingle, C. M. Haskell, et al. p27Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy J Natl Cancer Inst, December 6, 2006; 98(23): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Guo and R. S. Hartley HuR Contributes to Cyclin E1 Deregulation in MCF-7 Breast Cancer Cells Cancer Res., August 15, 2006; 66(16): 7948 - 7956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Spruck, D. Sun, H. Fiegl, C. Marth, E. Mueller-Holzner, G. Goebel, M. Widschwendter, and S. I. Reed Detection of low molecular weight derivatives of cyclin e1 is a function of cyclin e1 protein levels in breast cancer. Cancer Res., July 15, 2006; 66(14): 7355 - 7360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sieuwerts, M. P. Look, M. E. Meijer-van Gelder, M. Timmermans, A. M.A.C. Trapman, R. R. Garcia, M. Arnold, A. J.W. Goedheer, V. de Weerd, H. Portengen, et al. Which cyclin e prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin. Cancer Res., June 1, 2006; 12(11): 3319 - 3328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Kemp, A. Rowan, W. Chambers, N. Wortham, S. Halford, O. Sieber, N. Mortensen, A. von Herbay, T. Gunther, M. Ilyas, et al. CDC4 Mutations Occur in a Subset of Colorectal Cancers but Are Not Predicted to Cause Loss of Function and Are Not Associated with Chromosomal Instability Cancer Res., December 15, 2005; 65(24): 11361 - 11366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Libertini, B. S. Robinson, N. K. Dhillon, D. Glick, M. George, S. Dandekar, J. P. Gregg, E. Sawai, and M. Mudryj Cyclin E Both Regulates and Is Regulated by Calpain 2, a Protease Associated with Metastatic Breast Cancer Phenotype Cancer Res., December 1, 2005; 65(23): 10700 - 10708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Grimm, A. Contreras, M.-H. Barcellos-Hoff, and J. M. Rosen Cell Cycle Defects Contribute to a Block in Hormone-induced Mammary Gland Proliferation in CCAAT/Enhancer-binding Protein (C/EBP{beta})-null Mice J. Biol. Chem., October 28, 2005; 280(43): 36301 - 36309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wingate, N. Zhang, M. J. McGarhen, I. Bedrosian, J. W. Harper, and K. Keyomarsi The Tumor-specific Hyperactive Forms of Cyclin E Are Resistant to Inhibition by p21 and p27 J. Biol. Chem., April 15, 2005; 280(15): 15148 - 15157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Garcia, G. A. Brar, D. H. H. Nguyen, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the CDK2 Protein Complex J. Biol. Chem., March 11, 2005; 280(10): 8756 - 8764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Bani-Hani, N. M. Almasri, Y. S. Khader, F. M. Sheyab, and H. N. Karam Combined Evaluation of Expressions of Cyclin E and p53 Proteins as Prognostic Factors for Patients with Gastric Cancer Clin. Cancer Res., February 15, 2005; 11(4): 1447 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bales, L. Mills, N. Milam, M. McGahren-Murray, D. Bandyopadhyay, D. Chen, J. A. Reed, N. Timchenko, J. J. van den Oord, M. Bar-Eli, et al. The Low Molecular Weight Cyclin E Isoforms Augment Angiogenesis and Metastasis of Human Melanoma Cells In vivo Cancer Res., February 1, 2005; 65(3): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Brzezinski, A. Migodzinski, A. Toczek, J. Tazbir, and M. Dedecjus Patterns of Cyclin E, Retinoblastoma Protein, and p21Cip1/WAF1 Immunostaining in the Oncogenesis of Papillary Thyroid Carcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Pierson-Mullany and C. A. Lange Phosphorylation of Progesterone Receptor Serine 400 Mediates Ligand-Independent Transcriptional Activity in Response to Activation of Cyclin-Dependent Protein Kinase 2 Mol. Cell. Biol., December 15, 2004; 24(24): 10542 - 10557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Akli, P.-J. Zheng, A. S. Multani, H. F. Wingate, S. Pathak, N. Zhang, S. L. Tucker, S. Chang, and K. Keyomarsi Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast Cancer Cancer Res., May 1, 2004; 64(9): 3198 - 3208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Harwell, B. B. Mull, D. C. Porter, and K. Keyomarsi Activation of Cyclin-dependent Kinase 2 by Full Length and Low Molecular Weight Forms of Cyclin E in Breast Cancer Cells J. Biol. Chem., March 26, 2004; 279(13): 12695 - 12705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kronenwett, S. Huwendiek, C. Ostring, N. Portwood, U. J. Roblick, Y. Pawitan, A. Alaiya, R. Sennerstam, A. Zetterberg, and G. Auer Improved Grading of Breast Adenocarcinomas Based on Genomic Instability Cancer Res., February 1, 2004; 64(3): 904 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Reed, B. Sandstad, R. Holm, and J. M. Nesland The Prognostic Impact of Hormone Receptors and c-erbB-2 in Pregnancy-Associated Breast Cancer and Their Correlation with BRCAI and Cell Cycle Modulators International Journal of Surgical Pathology, April 1, 2003; 11(2): 65 - 74. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Keyomarsi, S. L. Tucker, T. A. Buchholz, M. Callister, Y. Ding, G. N. Hortobagyi, I. Bedrosian, C. Knickerbocker, W. Toyofuku, M. Lowe, et al. Cyclin E and Survival in Patients with Breast Cancer N. Engl. J. Med., November 14, 2002; 347(20): 1566 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Pardee Regulation, Restriction, and Reminiscences J. Biol. Chem., July 19, 2002; 277(30): 26709 - 26716. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Musgrove, L.-J. K. Hunter, C. S. L. Lee, A. Swarbrick, R. Hui, and R. L. Sutherland Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2 J. Biol. Chem., December 7, 2001; 276(50): 47675 - 47683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Smith, F. Raynaud, P. Workman, and L. R. Kelland Characterization of a Human Colorectal Carcinoma Cell Line with Acquired Resistance to Flavopiridol Mol. Pharmacol., November 1, 2001; 60(5): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Geng, Q. Yu, W. Whoriskey, F. Dick, K. Y. Tsai, H. L. Ford, D. K. Biswas, A. B. Pardee, B. Amati, T. Jacks, et al. Expression of cyclins E1 and E2 during mouse development and in neoplasia PNAS, October 25, 2001; (2001) 231487798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. J. Vaziri, L. M. Krumroy, P. Elson, G. T. Budd, G. Darlington, J. Myles, R. R. Tubbs, and G. Casey Breast Tumor Immunophenotype of BRCA1-Mutation Carriers Is Influenced by Age at Diagnosis Clin. Cancer Res., July 1, 2001; 7(7): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sawasaki, K. Shigemasa, Y. Shiroyama, T. Kusuda, T. Fujii, T. H. Parmley, T. J. O'Brien, and K. Ohama Cyclin E mRNA Overexpression in Epithelial Ovarian Cancers: Inverse Correlation with p53 Protein Accumulation Reproductive Sciences, May 1, 2001; 8(3): 179 - 185. [Abstract] [PDF]
|
|
|
|
|
|
B. A. Schmidt, A. Rose, C. Steinhoff, T. Strohmeyer, M. Hartmann, and R. Ackermann Up-Regulation of Cyclin-dependent Kinase 4/Cyclin D2 Expression but Down-Regulation of Cyclin-dependent Kinase 2/Cyclin E in Testicular Germ Cell Tumors Cancer Res., May 1, 2001; 61(10): 4214 - 4221. [Abstract] [Full Text]
|
|
|
|
|
|
H. Dosaka-Akita, F. Hommura, T. Mishina, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami A Risk-Stratification Model of Non-Small Cell Lung Cancers Using Cyclin E, Ki-67, and ras p21: Different Roles of G1 Cyclins in Cell Proliferation and Prognosis Cancer Res., March 1, 2001; 61(6): 2500 - 2504. [Abstract] [Full Text]
|
|
|
|
|
|
J Georgieva, P Sinha, and D Schadendorf Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions J. Clin. Pathol., March 1, 2001; 54(3): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Porter and K. Keyomarsi Novel splice variants of cyclin E with altered substrate specificity Nucleic Acids Res., December 1, 2000; 28(23): e101 - e101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-Z. J. Liao, X. Hou, S. Bai, S. Antonia Li, and J. J. Li Unusual deregulation of cell cycle components in early and frank estrogen-induced renal neoplasias in the Syrian hamster Carcinogenesis, December 1, 2000; 21(12): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, C. Danes, M. Lowe, T. W. Herliczek, and K. Keyomarsi Activation of the Estrogen-Signaling Pathway by p21WAF1/CIP1 in Estrogen Receptor-Negative Breast Cancer Cells J Natl Cancer Inst, September 6, 2000; 92(17): 1403 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Noguchi, Y. Dobashi, H. Minehara, M. Itoman, and T. Kameya Involvement of Cyclins in Cell Proliferation and Their Clinical Implications in Soft Tissue Smooth Muscle Tumors Am. J. Pathol., June 1, 2000; 156(6): 2135 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Antonescu, D. H. Leung, M. Dudas, M. Ladanyi, M. Brennan, J. M. Woodruff, and C. Cordon-Cardo Alterations of Cell Cycle Regulators in Localized Synovial Sarcoma : A Multifactorial Study with Prognostic Implications Am. J. Pathol., March 1, 2000; 156(3): 977 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fukuse, T. Hirata, H. Naiki, S. Hitomi, and H. Wada Prognostic Significance of Cyclin E Overexpression in Resected Non-Small Cell Lung Cancer Cancer Res., January 1, 2000; 60(2): 242 - 244. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Harwell, D. C. Porter, C. Danes, and K. Keyomarsi Processing of Cyclin E Differs between Normal and Tumor Breast Cells Cancer Res., January 1, 2000; 60(2): 481 - 489. [Abstract] [Full Text]
|
|
|
|
|
|
T. Mishina, H. Dosaka-Akita, F. Hommura, M. Nishi, T. Kojima, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami Cyclin E Expression, a Potential Prognostic Marker for Non-Small Cell Lung Cancers Clin. Cancer Res., January 1, 2000; 6(1): 11 - 16. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Del Pizzo, A. Borkowski, S. C. Jacobs, and N. Kyprianou Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient Survival Am. J. Pathol., October 1, 1999; 155(4): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. DONNELLAN and R. CHETTY Cyclin E in human cancers FASEB J, May 1, 1999; 13(8): 773 - 780. [Abstract] [Full Text]
|
|
|
|
|
|
F. Lonardo, V. Rusch, J. Langenfeld, E. Dmitrovsky, and D. S. Klimstra Overexpression of Cyclins D1 and E Is Frequent in Bronchial Preneoplasia and Precedes Squamous Cell Carcinoma Development Cancer Res., May 1, 1999; 59(10): 2470 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Gudas, M. Payton, S. Thukral, E. Chen, M. Bass, M. O. Robinson, and S. Coats Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers Mol. Cell. Biol., January 1, 1999; 19(1): 612 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Ahn, K. W. Kwon, Y. J. Choi, and N. H. Cho Expression of Cyclin E and Cyclin-Dependent Kinase Inhibitor, p27KIP1 in Uterine Endometrial Carcinoma: Relationship with p53 Status International Journal of Surgical Pathology, October 1, 1998; 6(4): 205 - 212. [Abstract] [PDF]
|
|
|
|
|
|
Y. Dobashi, M. Shoji, S.-X. Jiang, M. Kobayashi, Y. Kawakubo, and T. Kameya Active Cyclin A-CDK2 Complex, a Possible Critical Factor for Cell Proliferation in Human Primary Lung Carcinomas Am. J. Pathol., September 1, 1998; 153(3): 963 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iida, M. Towatari, M. Tanimoto, Y. Morishita, Y. Kodera, and H. Saito Overexpression of Cyclin E in Acute Myelogenous Leukemia Blood, November 1, 1997; 90(9): 3707 - 3713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Langenfeld, H. Kiyokawa, D. Sekula, J. Boyle, and E. Dmitrovsky Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism PNAS, October 28, 1997; 94(22): 12070 - 12074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gray-Bablin, J. Zalvide, M. P. Fox, C. J. Knickerbocker, J. A. DeCaprio, and K. Keyomarsi Cyclin E, a redundant cyclin in breast cancer PNAS, December 24, 1996; 93(26): 15215 - 15220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Sherr Cancer Cell Cycles Science, December 6, 1996; 274(5293): 1672 - 1677. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-F. Chang, D.-Y. Huang, and T.-C. Lai Different Regulation of the Human Thymidine Kinase Promoter in Normal Human Diploid IMR-90 Fibroblasts and HeLa Cells J. Biol. Chem., November 10, 1995; 270(45): 27374 - 27379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Roberts, A. Koff, K. Polyak, E. Firpo, S. Collins, M. Ohtsubo, and J. Massague Cyclins, Cdks, and Cyclin Kinase Inhibitors Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 31 - 38. [Abstract] [PDF]
|
|
|
|
|
|
O. W. J. Prall, J. S. Carroll, and R. L. Sutherland A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E{middle dot}Cdk2 J. Biol. Chem., November 21, 2001; 276(48): 45433 - 45442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Geng, Q. Yu, W. Whoriskey, F. Dick, K. Y. Tsai, H. L. Ford, D. K. Biswas, A. B. Pardee, B. Amati, T. Jacks, et al. Expression of cyclins E1 and E2 during mouse development and in neoplasia PNAS, November 6, 2001; 98(23): 13138 - 13143. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
